• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重发热伴血小板减少综合征病毒在I型干扰素信号通路调控的小鼠中的致病性:严重发热伴血小板减少与I型干扰素

Pathogenicity of severe fever with thrombocytopenia syndrome virus in mice regulated in type I interferon signaling: Severe fever with thrombocytopenia and type I interferon.

作者信息

Park Seok-Chan, Park Jun Young, Choi Jin Young, Lee Sung-Geun, Eo Seong Kug, Oem Jae-Ku, Tark Dong-Seob, You Myungjo, Yu Do-Hyeon, Chae Joon-Seok, Kim Bumseok

机构信息

College of Veterinary Medicine, Jeonbuk National University, Iksan, 54596 Republic of Korea.

Korea Zoonosis Research Institute, Jeonbuk National University, Iksan, 54531 Republic of Korea.

出版信息

Lab Anim Res. 2020 Oct 21;36:38. doi: 10.1186/s42826-020-00070-0. eCollection 2020.

DOI:10.1186/s42826-020-00070-0
PMID:33102200
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7579947/
Abstract

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging zoonotic disease, which causes high fever, thrombocytopenia, and death in humans and animals in East Asian countries. The pathogenicity of SFTS virus (SFTSV) remains unclear. We intraperitoneally infected three groups of mice: wild-type (WT), mice treated with blocking anti-type I interferon (IFN)-α receptor antibody (IFNAR Ab), and IFNAR knockout (IFNAR) mice, with four doses of SFTSV (KH1, 5 × 10 to 5 × 10 FAID). The WT mice survived all SFTSV infective doses. The IFNAR Ab mice died within 7 days post-infection (dpi) with all doses of SFTSV except that the mice were infected with 5 × 10 FAID SFTSV. The IFNAR mice died after infection with all doses of SFTSV within four dpi. No SFTSV infection caused hyperthermia in any mice, whereas all the dead mice showed hypothermia and weight loss. In the WT mice, SFTSV RNA was detected in the eyes, oral swabs, urine, and feces at 5 dpi. Similar patterns were observed in the IFNAR Ab and IFNAR mice after 3 dpi, but not in feces. The IFNAR Ab mice showed viral shedding until 7 dpi. The SFTSV RNA loads were higher in organs of the IFNAR mice compared to the other groups. Histopathologically, coagulation necrosis and mononuclear inflammatory cell infiltration in the liver and white pulp atrophy in the spleen were seen as the main lesions in the IFN signaling lacking mice. Immunohistochemically, SFTSV antigens were mainly detected in the marginal zone of the white pulp of the spleen in all groups of mice, but more viral antigens were observed in the spleen of the IFNAR mice. Collectively, the IFN signaling-deficient mice were highly susceptible to SFTSV and more viral burden could be demonstrated in various excreta and organs of the mice when IFN signaling was inhibited.

摘要

严重发热伴血小板减少综合征(SFTS)是一种新出现的人畜共患病,在东亚国家可导致人和动物出现高热、血小板减少及死亡。SFTS病毒(SFTSV)的致病性仍不清楚。我们将三组小鼠经腹腔感染:野生型(WT)小鼠、用抗I型干扰素(IFN)-α受体抗体(IFNAR Ab)阻断处理的小鼠以及IFNAR基因敲除(IFNAR)小鼠,用四剂SFTSV(KH1,5×10至5×10蚀斑形成单位)。所有感染剂量的SFTSV,WT小鼠均存活。除感染5×10蚀斑形成单位SFTSV的小鼠外,IFNAR Ab小鼠在感染所有剂量SFTSV后的7天内死亡。IFNAR小鼠在感染所有剂量SFTSV后的4天内死亡。任何剂量的SFTSV感染均未导致任何小鼠体温过高,而所有死亡小鼠均出现体温过低和体重减轻。在WT小鼠中,5天时在眼、口腔拭子、尿液和粪便中检测到SFTSV RNA。3天后在IFNAR Ab小鼠和IFNAR小鼠中观察到类似模式,但粪便中未观察到。IFNAR Ab小鼠在7天内均有病毒排出。与其他组相比,IFNAR小鼠器官中的SFTSV RNA载量更高。组织病理学上,在缺乏IFN信号的小鼠中,主要病变表现为肝脏的凝血性坏死和单核炎性细胞浸润以及脾脏白髓萎缩。免疫组织化学检测显示,所有组小鼠的脾脏白髓边缘区均主要检测到SFTSV抗原,但在IFNAR小鼠的脾脏中观察到更多病毒抗原。总体而言,IFN信号缺陷的小鼠对SFTSV高度易感,当IFN信号被抑制时,在小鼠的各种排泄物和器官中可显示出更多病毒负荷。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/7579947/fbecc214c946/42826_2020_70_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/7579947/836e0e708936/42826_2020_70_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/7579947/b8dc4d983c36/42826_2020_70_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/7579947/d00a4fc30136/42826_2020_70_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/7579947/286cd3ba8e32/42826_2020_70_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/7579947/84b66153375b/42826_2020_70_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/7579947/fbecc214c946/42826_2020_70_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/7579947/836e0e708936/42826_2020_70_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/7579947/b8dc4d983c36/42826_2020_70_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/7579947/d00a4fc30136/42826_2020_70_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/7579947/286cd3ba8e32/42826_2020_70_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/7579947/84b66153375b/42826_2020_70_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3dd/7579947/fbecc214c946/42826_2020_70_Fig6_HTML.jpg

相似文献

1
Pathogenicity of severe fever with thrombocytopenia syndrome virus in mice regulated in type I interferon signaling: Severe fever with thrombocytopenia and type I interferon.严重发热伴血小板减少综合征病毒在I型干扰素信号通路调控的小鼠中的致病性:严重发热伴血小板减少与I型干扰素
Lab Anim Res. 2020 Oct 21;36:38. doi: 10.1186/s42826-020-00070-0. eCollection 2020.
2
Difference in Intraspecies Transmissibility of Severe Fever with Thrombocytopenia Syndrome Virus Depending on Abrogating Type 1 Interferon Signaling in Mice.不同方法敲除小鼠Ⅰ型干扰素信号通路对发热伴血小板减少综合征病毒种间感染性的影响
Viruses. 2024 Mar 5;16(3):401. doi: 10.3390/v16030401.
3
Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus.T-705(法匹拉韦)治疗致死性严重发热伴血小板减少综合征病毒感染的疗效
mSphere. 2016 Jan 6;1(1). doi: 10.1128/mSphere.00061-15. eCollection 2016 Jan-Feb.
4
Species-Specific Pathogenicity of Severe Fever with Thrombocytopenia Syndrome Virus Is Determined by Anti-STAT2 Activity of NSs.严重发热伴血小板减少综合征病毒的种属特异性致病性由 NSs 对 STAT2 的拮抗活性决定。
J Virol. 2019 May 1;93(10). doi: 10.1128/JVI.02226-18. Print 2019 May 15.
5
Experimental infection of dogs with severe fever with thrombocytopenia syndrome virus: Pathogenicity and potential for intraspecies transmission.犬严重发热伴血小板减少综合征病毒感染实验:致病性和种内传播的可能性。
Transbound Emerg Dis. 2022 Sep;69(5):3090-3096. doi: 10.1111/tbed.14372. Epub 2021 Nov 12.
6
Modeling Severe Fever with Thrombocytopenia Syndrome Virus Infection in Golden Syrian Hamsters: Importance of STAT2 in Preventing Disease and Effective Treatment with Favipiravir.叙利亚金黄地鼠中严重发热伴血小板减少综合征病毒感染的建模:STAT2在预防疾病中的重要性及法匹拉韦的有效治疗作用
J Virol. 2017 Jan 18;91(3). doi: 10.1128/JVI.01942-16. Print 2017 Feb 1.
7
RIG-I-Like Receptor and Toll-Like Receptor Signaling Pathways Cause Aberrant Production of Inflammatory Cytokines/Chemokines in a Severe Fever with Thrombocytopenia Syndrome Virus Infection Mouse Model.RIG-I 样受体和 Toll 样受体信号通路导致严重发热伴血小板减少综合征病毒感染小鼠模型中炎症细胞因子/趋化因子的异常产生。
J Virol. 2018 Jun 13;92(13). doi: 10.1128/JVI.02246-17. Print 2018 Jul 1.
8
The pathogenesis of severe fever with thrombocytopenia syndrome virus infection in alpha/beta interferon knockout mice: insights into the pathologic mechanisms of a new viral hemorrhagic fever.α/β干扰素敲除小鼠严重发热伴血小板减少综合征病毒感染的发病机制:一种新的病毒性出血热病理机制的研究。
J Virol. 2014 Feb;88(3):1781-6. doi: 10.1128/JVI.02277-13. Epub 2013 Nov 20.
9
Cyclophilin A causes severe fever with thrombocytopenia syndrome virus-induced cytokine storm by regulating mitogen-activated protein kinase pathway.亲环素A通过调节丝裂原活化蛋白激酶途径引发严重发热伴血小板减少综合征病毒诱导的细胞因子风暴。
Front Microbiol. 2022 Dec 1;13:1046176. doi: 10.3389/fmicb.2022.1046176. eCollection 2022.
10
Construction and Characterization of Severe Fever with Thrombocytopenia Syndrome Virus with a Fluorescent Reporter for Antiviral Drug Screening.严重发热伴血小板减少综合征病毒荧光报告基因的构建与鉴定及其在抗病毒药物筛选中的应用
Viruses. 2023 May 10;15(5):1147. doi: 10.3390/v15051147.

引用本文的文献

1
Homologous and Heterologous Vaccination Regimens with mRNA and rVSV Platforms Induce Potent Immune Responses Against SFTSV Glycoprotein.使用mRNA和rVSV平台的同源和异源疫苗接种方案可诱导针对发热伴血小板减少综合征病毒糖蛋白的强效免疫反应。
Viruses. 2025 Aug 8;17(8):1095. doi: 10.3390/v17081095.
2
Latest advances and prospects in the pathogenesis, animal models, and vaccine research of severe fever with thrombocytopenia syndrome virus.发热伴血小板减少综合征病毒发病机制、动物模型及疫苗研究的最新进展与展望
Front Immunol. 2025 Jun 26;16:1624290. doi: 10.3389/fimmu.2025.1624290. eCollection 2025.
3
The public health threat of emerging phenuiviruses.

本文引用的文献

1
Clinical Score System to Differentiate Severe Fever with Thrombocytopenia Syndrome Patients from Patients with Scrub Typhus or Hemorrhagic Fever with Renal Syndrome in Korea.韩国用于区分严重发热伴血小板减少综合征患者与恙虫病或肾综合征出血热患者的临床评分系统。
J Korean Med Sci. 2020 Mar 23;35(11):e77. doi: 10.3346/jkms.2020.35.e77.
2
Antiviral Drugs Against Severe Fever With Thrombocytopenia Syndrome Virus Infection.抗严重发热伴血小板减少综合征病毒感染的抗病毒药物
Front Microbiol. 2020 Feb 11;11:150. doi: 10.3389/fmicb.2020.00150. eCollection 2020.
3
The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan.
新出现的白蛉病毒的公共卫生威胁。
One Health. 2025 May 6;20:101055. doi: 10.1016/j.onehlt.2025.101055. eCollection 2025 Jun.
4
An In-House ELISA for Anti-Porcine Circovirus Type 2d (PCV2d) IgG: Analytical Validation and Serological Correlation.用于抗2d型猪圆环病毒(PCV2d)IgG的内部酶联免疫吸附测定(ELISA):分析验证和血清学相关性
Vaccines (Basel). 2025 Jun 19;13(6):657. doi: 10.3390/vaccines13060657.
5
Tamdy virus pathogenesis in immunocompetent and immunocompromised mouse models.坦迪病毒在免疫功能正常和免疫功能低下小鼠模型中的发病机制。
Virulence. 2025 Dec;16(1):2503457. doi: 10.1080/21505594.2025.2503457. Epub 2025 May 12.
6
The immunogenicity and protection efficacy evaluation of mRNA vaccine candidate for severe fever with thrombocytopenia syndrome in mice.小鼠中严重发热伴血小板减少综合征mRNA候选疫苗的免疫原性和保护效果评估
PLoS Negl Trop Dis. 2025 Apr 30;19(4):e0012999. doi: 10.1371/journal.pntd.0012999. eCollection 2025 Apr.
7
Limitations of a proper SFTSV mouse model using human C-type lectin receptors.使用人类C型凝集素受体的合适的严重发热伴血小板减少综合征病毒(SFTSV)小鼠模型的局限性。
Front Microbiol. 2024 Dec 19;15:1452739. doi: 10.3389/fmicb.2024.1452739. eCollection 2024.
8
Discovery and characterization of potent broadly neutralizing antibodies from human survivors of severe fever with thrombocytopenia syndrome.从严重发热伴血小板减少综合征人类幸存者中发现并鉴定强效广谱中和抗体
EBioMedicine. 2025 Jan;111:105481. doi: 10.1016/j.ebiom.2024.105481. Epub 2024 Dec 6.
9
Adenovirus type 5-expressing Gn induces better protective immunity than Gc against SFTSV infection in mice.在小鼠中,表达5型腺病毒的Gn比Gc能诱导更好的针对发热伴血小板减少综合征病毒(SFTSV)感染的保护性免疫。
NPJ Vaccines. 2024 Oct 19;9(1):194. doi: 10.1038/s41541-024-00993-y.
10
Tick-borne viruses: Epidemiology, pathogenesis, and animal models.蜱传病毒:流行病学、发病机制及动物模型
One Health. 2024 Sep 25;19:100903. doi: 10.1016/j.onehlt.2024.100903. eCollection 2024 Dec.
台湾地区首例严重发热伴血小板减少综合征病毒感染的发现。
Emerg Microbes Infect. 2020 Jan 10;9(1):148-151. doi: 10.1080/22221751.2019.1710436. eCollection 2020.
4
Global virus outbreaks: Interferons as 1st responders.全球病毒爆发:干扰素作为第一反应者。
Semin Immunol. 2019 Jun;43:101300. doi: 10.1016/j.smim.2019.101300.
5
Severe Fever with Thrombocytopenia Syndrome Phlebovirus causes lethal viral hemorrhagic fever in cats.发热伴血小板减少综合征布尼亚病毒可引起猫致命性病毒性出血热。
Sci Rep. 2019 Aug 19;9(1):11990. doi: 10.1038/s41598-019-48317-8.
6
Complete Genome Sequences of Two Severe Fever with Thrombocytopenia Syndrome Virus Strains Isolated from a Human and a Dog in the Republic Of Korea.从韩国一名人类患者和一只犬类身上分离出的两株严重发热伴血小板减少综合征病毒的全基因组序列
Microbiol Resour Announc. 2019 Aug 1;8(31):e01695-18. doi: 10.1128/MRA.01695-18.
7
A Case of Cat-to-Human Transmission of Severe Fever with Thrombocytopenia Syndrome Virus.一例发热伴血小板减少综合征病毒猫传人病例
Jpn J Infect Dis. 2019 Sep 19;72(5):356-358. doi: 10.7883/yoken.JJID.2018.526. Epub 2019 Jul 31.
8
Nosocomial person-to-person transmission of severe fever with thrombocytopenia syndrome.严重发热伴血小板减少综合征的医院内人际传播。
Clin Microbiol Infect. 2019 May;25(5):633.e1-633.e4. doi: 10.1016/j.cmi.2019.01.006. Epub 2019 Jan 21.
9
Ferret animal model of severe fever with thrombocytopenia syndrome phlebovirus for human lethal infection and pathogenesis.雪貂动物模型严重发热伴血小板减少综合征病毒感染人体致死性和发病机制。
Nat Microbiol. 2019 Mar;4(3):438-446. doi: 10.1038/s41564-018-0317-1. Epub 2018 Dec 10.
10
The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts.世界卫生组织研发蓝图:需要紧急研发努力的新发传染病 2018 年审查。
Antiviral Res. 2018 Nov;159:63-67. doi: 10.1016/j.antiviral.2018.09.009. Epub 2018 Sep 24.